Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
1.
Rev Assoc Med Bras (1992) ; 64(7): 649-657, 2018 Jul.
Article in English | MEDLINE | ID: mdl-30365668

ABSTRACT

OBJECTIVE: The objective of this study was to evaluate the efficacy and safety of the harmonic scalpel compared to the conventional technique in patients submitted to total thyroidectomy. METHOD: This is a systematic review with inclusion of randomized controlled trials (RCTs) that compared both techniques. An electronic search was carried out in the Medline and Lilacs databases until June 2017. The outcomes analysed were operation time, intraoperative bleeding, surgical morbidity, and costs. RESULTS: Data from 31 primary studies were included. The use of the harmonic scalpel correlates to a shorter operation time (p <0.001) and a lower volume of intraoperative bleeding (p <0.001). There were no differences in the risk of transient (p = 0.53) and permanent (p = 0.70) hypocalcaemia, transient (p = 0.61) and permanent (p = 0.50) dysfunctions of the inferior laryngeal nerve and hematoma (p = 0.14). CONCLUSION: Total thyroidectomy using a harmonic scalpel is effective and safe compared to the conventional technique.


Subject(s)
Hemostasis, Surgical/instrumentation , Surgical Instruments , Thyroidectomy/instrumentation , Ultrasonic Surgical Procedures/instrumentation , Blood Loss, Surgical/prevention & control , Hemostasis, Surgical/economics , Humans , Operative Time , Randomized Controlled Trials as Topic , Surgical Instruments/economics , Thyroidectomy/economics , Ultrasonic Therapy
2.
Sci Rep ; 8(1): 11900, 2018 08 09.
Article in English | MEDLINE | ID: mdl-30093659

ABSTRACT

A therapeutic decision in the treatment of Tis/T1a glottic carcinoma with radiotherapy (RT) or transoral laser surgery (TOS) is still an open issue. Oncologic outcome and voice quality may support the choice for the latter To conduct a systematic review and meta-analysis to compare oncologic and functional outcomes of TOS and RT as treatment options for Tis/T1a glottic cancer. Literature research on online databases was carried out. Potentially eligible articles were reviewed. Relevant articles were selected and evaluated. There was statistical significance favoring patients initially treated with TOS when it comes to overall survival, disease-specific survival and larynx preservation. No difference in local control was found. TMF, Jitter and Shimmmer measurements presented statistically significant results in favor of RT. Self-assessment of voice quality (VHI) and f0 showed no statistically significant differences. Maximum Phonation Time (MPT) had a better response to RT. There is a trend in favor of RT. Tis/T1a glottic cancer patients submitted to TOS had significant overall and disease specific survival and had fewer risks of having a total laryngectomy, when compared to the radiotherapy group. The self-assessment of voice quality and f0 did not show any difference; however, Jitter, Shimmer and MPT measurements favored radiotherapy.


Subject(s)
Glottis/radiation effects , Glottis/surgery , Laryngeal Neoplasms/radiotherapy , Laryngeal Neoplasms/surgery , Laser Therapy/methods , Radiotherapy/methods , Humans , Mouth , Treatment Outcome , Voice Quality
3.
Rev. Assoc. Med. Bras. (1992, Impr.) ; 64(7): 649-657, July 2018. tab, graf
Article in English | LILACS | ID: biblio-976833

ABSTRACT

SUMMARY OBJECTIVE: The objective of this study was to evaluate the efficacy and safety of the harmonic scalpel compared to the conventional technique in patients submitted to total thyroidectomy. METHOD: This is a systematic review with inclusion of randomized controlled trials (RCTs) that compared both techniques. An electronic search was carried out in the Medline and Lilacs databases until June 2017. The outcomes analysed were operation time, intraoperative bleeding, surgical morbidity, and costs. RESULTS: Data from 31 primary studies were included. The use of the harmonic scalpel correlates to a shorter operation time (p <0.001) and a lower volume of intraoperative bleeding (p <0.001). There were no differences in the risk of transient (p = 0.53) and permanent (p = 0.70) hypocalcaemia, transient (p = 0.61) and permanent (p = 0.50) dysfunctions of the inferior laryngeal nerve and hematoma (p = 0.14). CONCLUSION: Total thyroidectomy using a harmonic scalpel is effective and safe compared to the conventional technique.


Subject(s)
Humans , Surgical Instruments/economics , Thyroidectomy/instrumentation , Ultrasonic Surgical Procedures/instrumentation , Hemostasis, Surgical/instrumentation , Thyroidectomy/economics , Ultrasonic Therapy , Randomized Controlled Trials as Topic , Blood Loss, Surgical/prevention & control , Operative Time , Hemostasis, Surgical/economics
4.
Oral Oncol ; 78: 114-118, 2018 03.
Article in English | MEDLINE | ID: mdl-29496038

ABSTRACT

BACKGROUND: Suspicion of mandibular invasion directly influences perioperative strategy, requiring marginal or segmental mandibulectomy, or reconstruction in some cases. This has a considerable impact on outcome and quality of life. The aim of this study was to evaluate the accuracy of magnetic resonance and computed tomography in the prediction of mandibular invasion in patients with oral cavity cancer. METHOD: A systematic review was conducted, including diagnostic studies comparing magnetic resonance imaging with computed tomography in the prediction of bone invasion. Sensitivity, specificity, positive and negative likelihood values and summary receiver operating characteristic (sROC) curves were calculated. RESULTS: The electronic and manual search identified 346 articles. Of these, 11 studies were included in the systematic review for a total of 477 patients. The sensitivity, specificity, and positive and negative likelihood values for MRI were 78%, 86%, 5.29 and 0.23, respectively. For CT, they were 76%, 89%, 6.00 and 0.28, respectively. The sROC curves for MRI and CT were 82.3% and 82.5%, respectively. CONCLUSION: No superiority was observed between the diagnostic methods regarding mandibular invasion detection.


Subject(s)
Magnetic Resonance Imaging/methods , Mandible/diagnostic imaging , Mandible/pathology , Mouth Neoplasms/pathology , Neoplasm Invasiveness/diagnostic imaging , Tomography, X-Ray Computed/methods , Humans
5.
ORL J Otorhinolaryngol Relat Spec ; 79(4): 222-229, 2017.
Article in English | MEDLINE | ID: mdl-28768272

ABSTRACT

INTRODUCTION: Since the introduction of tracheoesophageal puncture (TEP) and placement of voice prosthesis, this has become the method of choice to achieve speech rehabilitation after total laryngectomy. OBJECTIVE: To compare the complications and success in speech rehabilitation of patients undergoing rehabilitation after primary and secondary TEP (TEP1 and TEP2) through a systematic review. METHODS: The literature survey included research in MedLine, Scielo, Lilacs, Cochrane and Websco until June 2016. RESULTS: The rate of leakage around the prosthesis was higher in TEP1 (22.5 vs. 6.9%, p = 0.03). There were higher rates of wound infection (9.1 vs. 3.9%) and tracheal stenosis (8.5 vs. 4.5%) in the TEP1 group compared to TEP2, however with no statistical significance. The evaluation of speech quality was not possible due to the heterogeneity of the studies. CONCLUSION: There is a reduction in the risk of leakage around the prosthesis among TEP2 patients.


Subject(s)
Laryngectomy/rehabilitation , Larynx, Artificial , Esophagus/surgery , Humans , Laryngeal Neoplasms/surgery , Postoperative Complications , Prosthesis Failure , Prosthesis Implantation , Punctures , Trachea/surgery , Tracheal Stenosis/etiology , Tracheostomy/adverse effects
6.
ORL J Otorhinolaryngol Relat Spec ; 79(6): 347-355, 2017.
Article in English | MEDLINE | ID: mdl-29393250

ABSTRACT

OBJECTIVE: The aim of this study is to investigate the clinical and pathological factors related to distant metastasis in patients with oral cavity squamous cell carcinoma (OCSCC) undergoing surgery. STUDY DESIGN: A retrospective data review was conducted on patients who underwent primary surgery for OCSCC at the Instituto do Cancer do Estado de São Paulo (ICESP) between 2009 and 2015. Distant metastasis rates were calculated and predictive factors were determined by the Cox proportional-hazards model. RESULTS: There was a total of 274 patients, including 210 (76.6%) men and 64 (23.4%) women, with a mean age of 59.9 ± 10.9 years. The incidence of distant metastasis was 9.6%, with the lung being the most common site. The mean time interval between surgical treatment and the diagnosis of distant metastasis was 12 months (range 2-40 months). In the multivariate analysis, angiolymphatic invasion (HR = 2,87; p = 0.023), contralateral cervical metastasis (HR = 3.3; p = 0,007), tumor thickness >25 mm (HR = 3.50; p = 0.009), and locoregional recurrence (HR = 6.59; p < 0.0001) were the only independent risk factors for distant metastasis. CONCLUSION: Patients with OCSCC who have contralateral lymph node metastasis, tumors with a thickness >25 mm, angiolymphatic invasion, or locoregional recurrence after surgical treatment have a greater risk of developing distant metastasis.


Subject(s)
Carcinoma, Squamous Cell/pathology , Head and Neck Neoplasms/pathology , Mouth Neoplasms/pathology , Neoplasm Recurrence, Local/epidemiology , Adult , Aged , Aged, 80 and over , Brazil , Carcinoma, Squamous Cell/surgery , Cohort Studies , Female , Head and Neck Neoplasms/surgery , Humans , Incidence , Male , Middle Aged , Mouth/pathology , Mouth Neoplasms/surgery , Neoplasm Recurrence, Local/pathology , ROC Curve , Retrospective Studies , Risk Factors , Squamous Cell Carcinoma of Head and Neck
7.
Rev Assoc Med Bras (1992) ; 62(3): 243-7, 2016.
Article in English | MEDLINE | ID: mdl-27310548

ABSTRACT

INTRODUCTION: Hepatic encephalopathy (HE) is a bad prognostic factor in patients with liver cirrhosis and its incidence is associated with several triggering factors being the most prevalent gastrointestinal bleeding. Lactulose, despite its questionable efficacy in the literature, is considered a first line treatment in patients with HE. OBJECTIVE: To evaluate the effectiveness of lactulose in preventing HE in cirrhotic patients with gastrointestinal bleeding. METHOD: A systematic review of the literature using the Medline scientific database. Only randomized controlled clinical trials evaluating the efficacy of lactulose for HE prophylaxis in cirrhotic patients with gastrointestinal bleeding were included. RESULTS: The incidence of HE in the intervention group was 7%, while the control group was 26% (p=0.01). There was no significant difference in the incidence of mortality in the group treated with lactulose compared to the group that was not treated (p=0.48). CONCLUSION: Administering lactulose to cirrhotic patients with upper gastrointestinal bleeding reduces the incidence of hepatic encephalopathy.


Subject(s)
Gastrointestinal Agents/therapeutic use , Gastrointestinal Hemorrhage/drug therapy , Hepatic Encephalopathy/prevention & control , Lactulose/therapeutic use , Liver Cirrhosis/drug therapy , Female , Gastrointestinal Hemorrhage/mortality , Hepatic Encephalopathy/mortality , Humans , Liver Cirrhosis/mortality , Male , Randomized Controlled Trials as Topic , Reproducibility of Results , Treatment Outcome
8.
Rev. Assoc. Med. Bras. (1992, Impr.) ; 62(3): 243-247, May-June 2016. tab, graf
Article in English | LILACS | ID: lil-784316

ABSTRACT

SUMMARY Introduction: Hepatic encephalopathy (HE) is a bad prognostic factor in patients with liver cirrhosis and its incidence is associated with several triggering factors being the most prevalent gastrointestinal bleeding. Lactulose, despite its questionable efficacy in the literature, is considered a first line treatment in patients with HE. Objective: To evaluate the effectiveness of lactulose in preventing HE in cirrhotic patients with gastrointestinal bleeding. Method: A systematic review of the literature using the Medline scientific database. Only randomized controlled clinical trials evaluating the efficacy of lactulose for HE prophylaxis in cirrhotic patients with gastrointestinal bleeding were included. Results: The incidence of HE in the intervention group was 7%, while the control group was 26% (p=0.01). There was no significant difference in the incidence of mortality in the group treated with lactulose compared to the group that was not treated (p=0.48). Conclusion: Administering lactulose to cirrhotic patients with upper gastrointestinal bleeding reduces the incidence of hepatic encephalopathy.


RSUMO Introdução: encefalopatia hepática (EH) é fator de mau prognóstico no paciente com cirrose hepática e sua incidência está associada a vários fatores desencadeantes, sendo a hemorragia digestiva o mais prevalente. A lactulose, apesar de apresentar eficácia discutível na literatura, é considerada tratamento de primeira linha em pacientes com EH. Objetivo: avaliar a eficácia da lactulose na prevenção de EH em pacientes cirróticos apresentando hemorragia digestiva. Método: realizou-se revisão sistemática da literatura pela base de dados Medline. Foram incluídos apenas ensaios clínicos controlados e randomizados que avaliaram a eficácia da lactulose na profilaxia de EH em pacientes cirróticos com hemorragia digestiva. Resultados: a incidência de EH no grupo intervenção foi de 7% enquanto no grupo controle foi de 26% (p=0,01). Não houve diferença significante na incidência de mortalidade entre o grupo que recebeu lactulose e o que não recebeu (p=0,48). Conclusão: a administração de lactulose em pacientes cirróticos apresentando hemorragia digestiva alta diminui a incidência de encefalopatia hepática.


Subject(s)
Humans , Male , Female , Gastrointestinal Agents/therapeutic use , Hepatic Encephalopathy/prevention & control , Gastrointestinal Hemorrhage/drug therapy , Lactulose/therapeutic use , Liver Cirrhosis/drug therapy , Randomized Controlled Trials as Topic , Hepatic Encephalopathy/mortality , Reproducibility of Results , Treatment Outcome , Gastrointestinal Hemorrhage/mortality , Liver Cirrhosis/mortality
9.
Head Neck ; 38 Suppl 1: E2317-21, 2016 04.
Article in English | MEDLINE | ID: mdl-26559777

ABSTRACT

BACKGROUND: The role of pectoralis major muscle flap (PMMF) in reducing the rate of pharyngocutaneous fistula after salvage total laryngectomy has not been clearly established. The purpose of this study was to evaluate the impact of PMMF in reducing pharyngocutaneous fistula rates after total laryngectomy. METHODS: The analyzed intervention was the use of a PMMF after total laryngectomy. RESULTS: Pharyngocutaneous fistula occurred in 230 cases (global incidence, 30.9%). In the group of patients who underwent PMMFs, there were 49 cases of pharyngocutaneous fistula, compared with 181 cases in the control group. There was a 22% decreased risk of pharyngocutaneous fistula incidence in the PMMF group (p < .001). Patients who underwent a PMMF had lower risk of pharyngocutaneous fistula compared with the control group (p = .008). There were no changes when only patients who underwent total laryngectomy (p < .001) and those who underwent total pharyngolaryngectomy (p = .007) were separately assessed. CONCLUSION: Prophylactic use of PMMF decreases the incidence of pharyngocutaneous fistula after salvage total laryngectomy. © 2015 Wiley Periodicals, Inc. Head Neck 38: E2317-E2321, 2016.


Subject(s)
Cutaneous Fistula/prevention & control , Laryngeal Neoplasms/surgery , Laryngectomy , Pectoralis Muscles/transplantation , Pharyngeal Diseases/prevention & control , Surgical Flaps/transplantation , Humans , Retrospective Studies , Salvage Therapy
10.
Head Neck ; 37(10): 1532-5, 2015 Oct.
Article in English | MEDLINE | ID: mdl-24816775

ABSTRACT

BACKGROUND: Early oral feeding for patients who underwent total laryngectomy is still controversial. The purpose of this study was to evaluate the safety of initiating early oral feeding after total laryngectomy regarding pharyngocutaneous fistula. The survey included research in MEDLINE, EMBASE, and LILACS. METHODS: The intervention analyzed was early oral feeding (<5 days), whereas the control group received late oral feeding (>7 days) after total laryngectomy. RESULTS: From 304 studies, 4 randomized clinical trials with 180 patients were selected. In the early oral feeding group, the incidence was 6.7%, whereas in the late oral feeding group it was 10%, with no statistically significant difference (IC95% -0.11 to 0.05; p = .42; I(2) = 0%). Four cohort studies with 490 patients were also selected. In the early oral feeding group, the incidence was 12.2%, whereas in the other group, it was 10.1%, with no statistically significant difference (IC95% -0.05 to 0.08; p = .67; I2 = 0%). CONCLUSION: There is no increase in pharyngocutaneous fistula rates in patients who receive early oral feeding after total laryngectomy.


Subject(s)
Cutaneous Fistula/etiology , Enteral Nutrition/methods , Laryngeal Neoplasms/surgery , Laryngectomy , Pharyngeal Diseases/etiology , Postoperative Complications , Constriction, Pathologic/etiology , Female , Humans , Male , Postoperative Care , Surveys and Questionnaires , Time Factors
11.
Head Neck ; 37(11): 1691-7, 2015 Nov.
Article in English | MEDLINE | ID: mdl-24958209

ABSTRACT

BACKGROUND: Pharyngocutaneous fistula (PCF) is the most common surgical complication after total laryngectomy. Controversy still remains regarding the multiple risk factors implicated. The purpose of this study was to evaluate the potential risk factors for PCF. METHODS: The strategy for our literature survey included research in MEDLINE up to December 2013. The risk factors analyzed were age, sex, smoking habit, alcohol use, comorbidity, preoperative hemoglobin level, blood transfusion, preoperative tracheotomy, previous radiotherapy and chemoradiotherapy, primary tumor site, T classification, cartilage invasion, tumor grade, surgical margins, suture material, second layer of suture, reconstruction, tracheoesophageal prosthesis, and neck dissection. RESULTS: The electronic search resulted in 311 studies from which 63 met the inclusion criteria. CONCLUSION: Chronic obstructive pulmonary disease (COPD), previous hemoglobin <12.5g/dL, blood transfusion, previous radiotherapy or chemoradiotherapy, advanced primary tumors, supraglottic subsite, hypopharyngeal tumor site, positive surgical margins, and the performance of neck dissection were risk factors for PCF.


Subject(s)
Comorbidity , Cutaneous Fistula/etiology , Laryngeal Neoplasms/surgery , Laryngectomy/adverse effects , Pharyngeal Diseases/etiology , Age Factors , Aged , Cutaneous Fistula/physiopathology , Female , Humans , Incidence , Laryngeal Neoplasms/pathology , Laryngectomy/methods , Male , Middle Aged , Neck Dissection/adverse effects , Neck Dissection/methods , Pharyngeal Diseases/physiopathology , Postoperative Complications/diagnosis , Postoperative Complications/epidemiology , Prognosis , Risk Assessment , Sex Factors
12.
Rev Gastroenterol Peru ; 34(3): 217-24, 2014 Jul.
Article in English | MEDLINE | ID: mdl-25293990

ABSTRACT

BACKGROUND: Barrett's esophagus (BE) is the main risk factor for esophageal adenocarcinoma. Its therapeutic approach is controversial and surgical treatment in the presence of high-grade intraepithelial neoplasia may be indicated. Endoscopic approach is an alternative with lower mortality and morbidity rates and favorable results. OBJECTIVE: To define the best option, according to literature, to treat Barrett's Esophagus. DESIGN: Systematic review of PUBMED, EMBASE, LILACS, and Cochrane Library databases was conducted and articles of randomized, controlled studies on BE endoscopic ablative treatment were selected. The systematic review through PUBMED retrieved results with higher evidence level and available recommendation grade regarding BE ablative therapy. Nine articles on randomized, controlled studies classified as A or B according to the Oxford table were selected. Cryotherapy, laser, photodynamic therapy (PDT), multipolar electrocoagulation (MPEC), and ablation through argon plasma coagulation (APC) and radiofrequency were considered ablation therapies. PATIENTS: 649 patients from 10 different studies were analysed. RESULTS: PDT was found to present an increase in treatment failure compared with APC, NNH = -7. BE ablation through MPEC or APC was found to have similar risk for treatment failure in meta-analysis. PDT associated with proton pump inhibitor (PPI) is beneficial for BE ablation regarding PPI use alone, NNT = 2.Radiofrequency with PPI is an efficient method to reduce risk of treatment failure, NNT = 1. CONCLUSIONS: There are no studies demonstrating the benefit of indicating cryotherapy or laser therapy for BE endoscopic approach. APC ablation was found to have superior efficacy compared with PDT and ablation through APC and MPEC was found to present effective, similar results. Radiofrequency is the most recent approach requiring comparative studies for indication.


Subject(s)
Ablation Techniques , Barrett Esophagus/surgery , Esophagoscopy , Humans
13.
Rev. Assoc. Med. Bras. (1992, Impr.) ; 59(4): 387-391, jul.-ago. 2013. ilus, tab
Article in Portuguese | LILACS | ID: lil-685532

ABSTRACT

OBJETIVO: Verificar a eficácia da dexametasona na profilaxia de náuseas e vômitos em pacientes submetidos à colecistectomia laparoscópica. MÉTODOS: Revisão sistemática da literatura através das bases de dados MEDLINE, EMBASE e LILACS. Foram incluídos apenas ensaios clínicos controlados e randomizados que compararam a dexametasona ao placebo na profilaxia de náusea e vômito em pacientes submetidos à colecistectomia laparoscópica. RESULTADOS: Os resultados desta revisão basearam-se em dados de 12 ensaios clínicos controlados e randomizados, totalizando 947 pacientes. O grupo de pacientes que recebeu dexametasona pré-operatória apresentou menor incidência de náusea (NNT = 7), de vômito (NNT = 7) e de necessidade de antieméticos de resgate (NNT = 6). CONCLUSÃO: A infusão pré-operatória de 8 mg de dexametasona diminui o risco de complicações no pós-operatório de pacientes submetidos à colecistectomia laparoscópica.


OBJECTIVE: To verify the efficacy of dexamethasone in the prophylaxis of nausea and vomiting Laparoscopic cholecystectomy in patients submitted to laparoscopic cholecystectomy. Cholelithiasis METHODS: This was a systematic review of the literature through the MEDLINE, Embase, and Dexamethasone LILACS databases. Only controlled and randomized clinical trials comparing dexamethasone Postoperative nausea and vomiting to placebo in the prophylaxis of nausea and vomiting in patients submitted to laparoscopic cholecystectomy were included. RESULTS: The results of this review were based on data from 12 controlled and randomized clinical trials, totaling 947 patients. The group of patients who received preoperative dexamethasone showed lower incidence of nausea (number needed to treat [NNT] = 7), vomiting (NNT = 7), and need for smaller doses of rescue antiemetics (NNT = 6). CONCLUSION: The preoperative infusion of 8 mg of dexamethasone decreases the risk of complications in the postoperative period for patients submitted to laparoscopic cholecystectomy.


Subject(s)
Humans , Antiemetics/therapeutic use , Cholecystectomy, Laparoscopic/adverse effects , Dexamethasone/therapeutic use , Postoperative Nausea and Vomiting/prevention & control , Postoperative Period , Randomized Controlled Trials as Topic , Treatment Outcome
14.
Rev Assoc Med Bras (1992) ; 59(4): 387-91, 2013.
Article in English, Portuguese | MEDLINE | ID: mdl-23866937

ABSTRACT

OBJECTIVE: To verify the efficacy of dexamethasone in the prophylaxis of nausea and vomiting in patients submitted to laparoscopic cholecystectomy. METHODS: This was a systematic review of the literature through the MEDLINE, Embase, and LILACS databases. Only controlled and randomized clinical trials comparing dexamethasone to placebo in the prophylaxis of nausea and vomiting in patients submitted to laparoscopic cholecystectomy were included. RESULTS: The results of this review were based on data from 12 controlled and randomized clinical trials, totaling 947 patients. The group of patients who received preoperative dexamethasone showed lower incidence of nausea (number needed to treat [NNT]=7), vomiting (NNT=7), and need for smaller doses of rescue antiemetics (NNT=6). CONCLUSION: The preoperative infusion of 8 mg of dexamethasone decreases the risk of complications in the postoperative period for patients submitted to laparoscopic cholecystectomy.


Subject(s)
Antiemetics/therapeutic use , Cholecystectomy, Laparoscopic/adverse effects , Dexamethasone/therapeutic use , Postoperative Nausea and Vomiting/prevention & control , Humans , Postoperative Period , Randomized Controlled Trials as Topic , Treatment Outcome
15.
J Pediatr (Rio J) ; 89(1): 18-24, 2013.
Article in English | MEDLINE | ID: mdl-23544806

ABSTRACT

OBJECTIVE: To elucidate the benefits of using probiotics in the prevention of necrotizing enterocolitis (NEC) and its complications in preterm newborns. METHOD: This was a systematic review of randomized controlled trials, which included studies retrieved from three databases (MEDLINE, Embase, and LILACS), using a combination of the terms (necrotizing enterocolitis) AND (probiotics). RESULTS: 11 randomized trials were included, totaling 2,887 patients, 1,431 in the probiotic group and 1,456 in the control group. There was a reduction in the incidence of NEC (NNT=25), overall death (NNT=34), and neonatal sepsis (NNT=34) in the probiotic group compared to the control group. Patients that received probiotic supplementation had lower food reintroduction time (p<0.001) and hospitalization time (p<0.001) when compared to those not receiving probiotics. There was no difference in mortality caused by NEC. CONCLUSION: In premature newborns, the use of probiotics is effective as a prophylaxis for NEC and its complications.


Subject(s)
Enterocolitis, Necrotizing/prevention & control , Infant, Premature , Probiotics/therapeutic use , Enteral Nutrition/statistics & numerical data , Enterocolitis, Necrotizing/mortality , Hospitalization/statistics & numerical data , Humans , Infant, Newborn , Infant, Very Low Birth Weight , Randomized Controlled Trials as Topic , Sepsis/epidemiology
16.
J. pediatr. (Rio J.) ; 89(1): 18-24, jan.-fev. 2013. ilus, tab
Article in Portuguese | LILACS | ID: lil-668821

ABSTRACT

OBJETIVO: Elucidar os benefícios do uso de probióticos na prevenção de enterocolite necrosante (ECN) e de suas complicações em recém-nascidos prematuros. MÉTODO: Revisão sistemática de ensaios clínicos randomizados, que incluiu pesquisas efetuadas em três bases de dados (MEDLINE, EMBASE e LILACS), utilizando a combinação dos termos (necrotizing enterocolitis) AND (probiotics). RESULTADOS : Foram incluídos 11 ensaios clínicos randomizados, totalizando 2.887 pacientes, sendo 1.431 no grupo Probiótico e 1.456 no grupo Controle. Houve redução na incidência de ECN (NNT = 25), de morte global (NNT = 34) e sepse neonatal (NNT = 34) no grupo Probiótico em relação ao grupo Controle. Pacientes alimentados com suplementação de probióticos tiveram tempo de reintrodução alimentar (p < 0,001) e de hospitalização (p < 0,001) menor quando comparados aos que não receberam. Não houve diferença na mortalidade causada por ECN. CONCLUSÃO: Em recém-nascidos prematuros, o uso de probióticos é eficaz na profilaxia de ECN e de suas complicações.


OBJECTIVE: To elucidate the benefits of using probiotics in the prevention of necrotizing enterocolitis (NEC) and its complications in preterm newborns. METHOD: This was a systematic review of randomized controlled trials, which included studies retrieved from three databases (MEDLINE, Embase, and LILACS), using a combination of the terms (necrotizing enterocolitis) AND (probiotics). RESULTS: 11 randomized trials were included, totaling 2,887 patients, 1,431 in the probiotic group and 1,456 in the control group. There was a reduction in the incidence of NEC (NNT = 25), overall death (NNT = 34), and neonatal sepsis (NNT = 34) in the probiotic group compared to the control group. Patients that received probiotic supplementation had lower food reintroduction time (p < 0.001) and hospitalization time (p < 0.001) when compared to those not receiving probiotics. There was no difference in mortality caused by NEC. CONCLUSION: In premature newborns, the use of probiotics is effective as a prophylaxis for NEC and its complications.


Subject(s)
Humans , Infant, Newborn , Enterocolitis, Necrotizing/prevention & control , Infant, Premature , Probiotics/therapeutic use , Enteral Nutrition/statistics & numerical data , Enterocolitis, Necrotizing/mortality , Hospitalization/statistics & numerical data , Infant, Very Low Birth Weight , Randomized Controlled Trials as Topic , Sepsis/epidemiology
17.
Braz. j. otorhinolaryngol. (Impr.) ; 78(6): 94-98, nov.-dez. 2012. tab
Article in Portuguese | LILACS | ID: lil-660418

ABSTRACT

A fístula faringocutânea (FFC) é a complicação mais comum após a laringectomia total. OBJETIVOS: Estabelecer a incidência dessa complicação e analisar seus fatores predisponentes. MÉTODO: Este estudo é uma coorte histórica transversal que incluiu 94 pacientes submetidos à laringectomia total. Os seguintes aspectos foram relacionados ao surgimento de FFC: gênero, idade, sítio do tumor, estadiamento patológico conforme o TNM, o tipo de esvaziamento cervical realizado, radioterapia e traqueostomia prévias e o uso de grampeador para fechamento faríngeo. Nos casos de FFC, considerou-se o dia pós-operatório de seu diagnóstico, duração e abordagem terapêutica. RESULTADOS: FFC foi diagnosticada em 20 pacientes (21,3%). Houve incidência significativamente maior na de FFC no estadiamento T4 comparado com T2/T3 (p = 0,03). Os demais aspectos não apresentaram diferença estatística. Entretanto, 40,9% dos pacientes que se submeteram à traqueostomia prévia desenvolveram fístula, contra 21,1% dos pacientes fora dessa condição. CONCLUSÕES: Estadiamento avançado do tumor primário é um fator prognóstico para FFC.


Pharyngocutaneous fistula (PCF) is the most common complication after total laryngectomy. OBJECTIVES: To establish the incidence of this complication and to analyze the predisposing factors. METHOD: This is a cross-sectional study of a historical cohort including 94 patients who underwent total laryngectomy. The following aspects were correlated to the occurrence of PCF: gender, age, tumor site, TNM staging, type of neck dissection, previous radiation therapy, previous tracheotomy, and use of stapler for pharyngeal closure. The following were considered in PCF cases: the day into postoperative care when the fistula was diagnosed, duration of occurrence, and proposed treatment. RESULTS: Twenty (21.3%) patients had PCF. The incidence of PCF was statistically higher in T4 tumors when compared to T2 and T3 neoplasms (p = 0.03). The other analyzed correlations were not statistically significant. However, 40.9% of the patients submitted to tracheostomy previously had fistulae, against 21.1% of the patients not submitted to this procedure. CONCLUSION: Advanced primary tumor staging is correlated with higher incidences of PCF.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Cutaneous Fistula/etiology , Fistula/etiology , Laryngectomy/adverse effects , Pharyngeal Diseases/etiology , Cross-Sectional Studies , Carcinoma, Squamous Cell/surgery , Laryngeal Neoplasms/surgery , Risk Factors
18.
Rev Assoc Med Bras (1992) ; 58(3): 319-22, 2012.
Article in English, Portuguese | MEDLINE | ID: mdl-22735223

ABSTRACT

OBJECTIVE: To evaluate the efficacy of the association of corticosteroids and the standard treatment of bacterial meningitis in pediatric patients. METHODS: A systematic review of the literature was conducted through the MEDLINE database. Only randomized controlled trials comparing dexamethasone with placebo in the treatment of pediatric patients with bacterial meningitis were included. RESULTS: Eight articles met the inclusion criteria and were selected for analysis. There were no difference in mortality (p = 0.86), and incidence of neurological (p = 0.41) and auditory (p = 0.48) sequelae between the groups. CONCLUSION: There are no benefits in associating corticosteroids with the standard treatment of bacterial meningitis in pediatric patients.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Dexamethasone/administration & dosage , Glucocorticoids/administration & dosage , Meningitis, Bacterial/drug therapy , Child , Drug Therapy, Combination/methods , Humans , Meningitis, Bacterial/complications , Randomized Controlled Trials as Topic , Treatment Outcome
19.
Rev. Assoc. Med. Bras. (1992, Impr.) ; 58(3): 319-322, May-June 2012. ilus
Article in Portuguese | LILACS | ID: lil-639555

ABSTRACT

OBJETIVO: Avaliar a eficácia da associação de corticoide ao tratamento padrão da meningite bacteriana em pacientes pediátricos. MÉTODOS: Realizou-se revisão sistemática da literatura através da base de dados MEDLINE. Foram incluídos apenas ensaios clínicos controlados e randomizados que comparassem a dexametasona ao placebo no tratamento de pacientes pediátricos com meningite bacteriana. RESULTADOS: Oito artigos preencheram os critérios de inclusão e foram selecionados para análise. Não houve diferença nas taxas de mortalidade (p = 0,86) ou de incidências de sequelas neurológicas (p = 0,41) e audiológicas (p = 0,48) entre os grupos. CONCLUSÃO: Não existem benefícios na associação de corticoide ao tratamento da meningite bacteriana em pacientes pediátricos.


OBJECTIVE: To evaluate the efficacy of the association of corticosteroids and the standard treatment of bacterial meningitis in pediatric patients. METHODS: A systematic review of the literature was conducted through the MEDLINE database. Only randomized controlled trials comparing dexamethasone with placebo in the treatment of pediatric patients with bacterial meningitis were included. RESULTS: Eight articles met the inclusion criteria and were selected for analysis. There were no difference in mortality (p = 0.86), and incidence of neurological (p = 0.41) and auditory (p = 0.48) sequelae between the groups. CONCLUSION: There are no benefits in associating corticosteroids with the standard treatment of bacterial meningitis in pediatric patients.


Subject(s)
Child , Humans , Anti-Bacterial Agents/administration & dosage , Dexamethasone/administration & dosage , Glucocorticoids/administration & dosage , Meningitis, Bacterial/drug therapy , Drug Therapy, Combination/methods , Meningitis, Bacterial/complications , Randomized Controlled Trials as Topic , Treatment Outcome
20.
Braz J Otorhinolaryngol ; 78(6): 94-8, 2012 Dec.
Article in Portuguese | MEDLINE | ID: mdl-23306575

ABSTRACT

UNLABELLED: Pharyngocutaneous fistula (PCF) is the most common complication after total laryngectomy. OBJECTIVES: To establish the incidence of this complication and to analyze the predisposing factors. METHOD: This is a cross-sectional study of a historical cohort including 94 patients who underwent total laryngectomy. The following aspects were correlated to the occurrence of PCF: gender, age, tumor site, TNM staging, type of neck dissection, previous radiation therapy, previous tracheotomy, and use of stapler for pharyngeal closure. The following were considered in PCF cases: the day into postoperative care when the fistula was diagnosed, duration of occurrence, and proposed treatment. RESULTS: Twenty (21.3%) patients had PCF. The incidence of PCF was statistically higher in T4 tumors when compared to T2 and T3 neoplasms (p = 0.03). The other analyzed correlations were not statistically significant. However, 40.9% of the patients submitted to tracheostomy previously had fistulae, against 21.1% of the patients not submitted to this procedure. CONCLUSION: Advanced primary tumor staging is correlated with higher incidences of PCF.


Subject(s)
Cutaneous Fistula/etiology , Fistula/etiology , Laryngectomy/adverse effects , Pharyngeal Diseases/etiology , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/surgery , Cross-Sectional Studies , Female , Humans , Laryngeal Neoplasms/surgery , Male , Middle Aged , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...